You are here

Article info

Article menu
Valvular heart disease
Original article
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

Authors

  1. Correspondence to Professor Günter Breithardt, Division of Electrophysiology, Department of Cardiovascular Medicine, University Hospital Münster, Münster, Germany; g.breithardt{at}uni-muenster.de
View Full Text

Citation

Breithardt G, Baumgartner H, Berkowitz SD for the ROCKET AF Steering Committee & Investigators, et al
Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
Heart 2016;102:1036-1043.

Publication history

  • Received May 21, 2015
  • Revised January 20, 2016
  • Accepted January 26, 2016
  • First published February 17, 2016.
Online issue publication 
February 13, 2020

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/